CORZZ
Income statement / Annual
Last year (2023), Core Scientific, Inc. Tranche 2 Warrants's total revenue was $502.40 M,
a decrease of 21.54% from the previous year.
In 2023, Core Scientific, Inc. Tranche 2 Warrants's net income was -$246.49 M.
See Core Scientific, Inc. Tranche 2 Warrants,s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
| Period Ended |
12/31/2023 |
12/31/2022 |
12/31/2021 |
12/31/2020 |
12/31/2019 |
| Operating Revenue |
$502.40 M
|
$640.31 M
|
$544.48 M
|
$60.32 M
|
$59.52 M
|
| Cost of Revenue |
$378.94 M |
$631.91 M |
$305.62 M |
$50.93 M |
$49.00 M |
| Gross Profit |
$123.46 M |
$8.40 M |
$238.86 M |
$9.39 M |
$10.53 M |
| Gross Profit Ratio |
0.25 |
0.01 |
0.44 |
0.16 |
0.18 |
| Research and Development
Expenses |
$7.18 M
|
$26.96 M
|
$7.67 M
|
$5.27 M
|
$5.48 M
|
| General & Administrative
Expenses |
$93.91 M
|
$213.28 M
|
$60.49 M
|
$14.55 M
|
$13.78 M
|
| Selling & Marketing
Expenses |
$7.02 M
|
$12.73 M
|
$4.06 M
|
$1.77 M
|
$2.83 M
|
| Selling, General &
Administrative Expenses |
$100.93 M
|
$226.01 M
|
$64.55 M
|
$10,400.00
|
$16.61 M
|
| Other Expenses |
$6.39 M |
-$192.09 M |
-$16.05 M |
-$110,000.00 |
$0.00 |
| Operating Expenses |
$114.50 M |
$252.97 M |
$72.22 M |
$10,400.00 |
$22.21 M |
| Cost And Expenses |
$493.44 M |
$884.89 M |
$377.84 M |
$10,400.00 |
$71.21 M |
| Interest Income |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$235,000.00 |
| Interest Expense |
$86.24 M |
$96.83 M |
$44.35 M |
$4.44 M |
$235,000.00 |
| Depreciation &
Amortization |
$96.45 M
|
$226.09 M
|
$33.36 M
|
$9.40 M
|
$6.12 M
|
| EBITDA |
-$63.12 M
|
-$1.84 B
|
$167.61 M
|
-$10,400.00
|
-$4.64 M
|
| EBITDA Ratio |
-0.13 |
-0.03 |
0.37 |
-0 |
-0.08 |
| Operating Income Ratio
|
0.02
|
-0.38
|
0.31
|
-0
|
-0.18
|
| Total Other
Income/Expenses Net |
-$254.77 M
|
-$53.86 M
|
-$68.42 M
|
-$5.88 M
|
-$235,000.00
|
| Income Before Tax |
-$245.80 M |
-$2.16 B |
$63.08 M |
-$10,400.00 |
-$11.92 M |
| Income Before Tax Ratio
|
-0.49
|
-3.38
|
0.12
|
-0
|
-0.2
|
| Income Tax Expense |
$683,000.00 |
-$17.09 M |
$15.76 M |
-$4.97 M |
$0.00 |
| Net Income |
-$246.49 M |
-$2.15 B |
$47.31 M |
-$10,400.00 |
-$11.92 M |
| Net Income Ratio |
-0.49 |
-3.35 |
0.09 |
-0 |
-0.2 |
| EPS |
-0.65 |
-6.3 |
0.23 |
-0.0002 |
-0.12 |
| EPS Diluted |
-0.65 |
-6.3 |
0.2 |
-0.0002 |
-0.12 |
| Weighted Average Shares
Out |
$379.86 M
|
$340.65 M
|
$207.26 M
|
$43.13 M
|
$98.68 M
|
| Weighted Average Shares
Out Diluted |
$379.86 M
|
$340.65 M
|
$233.31 M
|
$43.13 M
|
$98.68 M
|
| Link |
|
|
|
|
|
